pharmaceuticals

“This medicine could be one of our largest medicines in history,” Novartis CEO Vas Narasimhan told CNBC on…

Eli Lilly on Thursday reported third-quarter earnings and revenue that blew past estimates and hiked its full-year sales…

Richmond—Not far from where highways I-95 and I-64 meet in Richmond, Virginia, there’s a quiet biotech park…

Jim Cramer said Monday that even tech-focused people think the world of Eli Lilly stock, with one predicting…

Amid ongoing angst over prescription drug prices, a new analysis found the median net price for 202 newly…

A costly jab. As more information is coming to light about one of the newest’s weight loss drug,…

During my years as a clinical pharmacist, I thought I understood why patients stopped taking long-term medications —…

In LUCENT-2, more than one in four (27.7%) Omvoh-treated patients with ulcerative colitis achieved comprehensive disease control, a…

UnitedHealth Group signage on the floor of the New York Stock Exchange on April 21, 2025. Michael Nagle…

Japan wants pharmaceuticals and advanced medicine to drive its next phase of economic growth. But achieving that goal…

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…

In TRIUMPH-2, participants with obesity and type 2 diabetes taking retatrutide 12 mg lost an average of 49.6…

Novartis remibrutinib MS drug faces efficacy questions